This opportunity is no longer accepting applications.
grant RFA-RM-24-007

Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed)

This grant opportunity is for applicants interested in improving and understanding technologies and tests that could be used in regulatory submissions for genome editing therapies.

The purpose of this Notice Of Funding Opportunity (NOFO) is to solicit applications on the optimization and characterization of technologies and assays with the potential for utilization and adoption in regulatory submissions of genome editing therapeutics.

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Opportunity Released: March 22, 2024
Open for Submission: March 22, 2024
Application Window Closes: July 26, 2024
Submission Deadline: July 26, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.